Literature DB >> 8478016

Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thüringen).

A Thieme1, B Mitulla, F Schulze, A W Spiegler.   

Abstract

This study contains the largest body of epidemiological data on Werdnig-Hoffmann disease (acute infantile spinal muscular atrophy; ASMA) in West-Thüringen in Germany. The incidence of ASMA was calculated to be 1 in 10,202 live births. The prevalence was 1 in 595,362 of the general population (as of 31 December 1987). The study gives an unexpectedly high incidence rate confirming the suggestion that ASMA in Central and Eastern Europe might be more frequent than in Western Europe. However, we consider that this high incidence rate in West-Thüringen is a result of the almost complete ascertainment made possible because of the well-organised and centralised health system existing in Thüringen over the last few decades.

Entities:  

Mesh:

Year:  1993        PMID: 8478016     DOI: 10.1007/bf00218278

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

1.  Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q).

Authors:  T L Munsat; L Skerry; B Korf; B Pober; Y Schapira; G G Gascon; S M al-Rajeh; V Dubowitz; K Davies; L M Brzustowicz
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

2.  High incidence of spinal muscular atrophy type I (Werdnig - Hoffmann disease) in the Karaite community in Israel.

Authors:  K Fried; G Mundel
Journal:  Clin Genet       Date:  1977-10       Impact factor: 4.438

3.  Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3.

Authors:  L M Brzustowicz; T Lehner; L H Castilla; G K Penchaszadeh; K C Wilhelmsen; R Daniels; K E Davies; M Leppert; F Ziter; D Wood
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

4.  The gene frequency of acute Werdnig-Hoffmann disease (SMA type 1). A total population survey in North-East England.

Authors:  J H Pearn
Journal:  J Med Genet       Date:  1973-09       Impact factor: 6.318

5.  Infantile and juvenile spinal muscular atrophy.

Authors:  I Hausmanowa-Petrusewicz; W Askanas; B Badurska; B Emeryk; A Fidziańska; W Garbalińska; L Hetnarska; Z Kamieniecka; J Prot; I Niebrój-Dobosz; H Jedrzejowska; E Sawicka
Journal:  J Neurol Sci       Date:  1968 Mar-Apr       Impact factor: 3.181

6.  A clinical, epidemiological and genetic study of hereditary motor neuropathies in Benghazi, Libya.

Authors:  K Radhakrishnan; A K Thacker; J C Maloo
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

Review 7.  The nosology of the spinal muscular atrophies.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1971-12       Impact factor: 6.318

8.  A hungarian study on Werdnig-Hoffmann disease.

Authors:  A Czeizel; J Hamula
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

9.  Cluster of acute infantile spinal muscular atrophy (Werdnig-Hoffmann disease) in a limited area of Reunion Island.

Authors:  M J Pascalet-Guidon; E Bois; J Feingold; J F Mattei; J C Combes; C Hamon
Journal:  Clin Genet       Date:  1984-07       Impact factor: 4.438

10.  Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators.

Authors:  J Melki; P Sheth; S Abdelhak; P Burlet; M F Bachelot; M G Lathrop; J Frezal; A Munnich
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

View more
  6 in total

1.  Chronic childhood spinal muscular atrophy in Germany (West-Thüringen)--an epidemiological study.

Authors:  A Thieme; B Mitulla; F Schulze; A W Spiegler
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

2.  Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.

Authors:  Lars Brichta; Lutz Garbes; Maria Jedrzejowska; Sushma-Nagaraja Grellscheid; Irmgard Holker; Katharina Zimmermann; Brunhilde Wirth
Journal:  Hum Genet       Date:  2008-01-03       Impact factor: 4.132

3.  Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5.

Authors:  G van der Steege; P M Grootscholten; J M Cobben; S Zappata; H Scheffer; J T den Dunnen; G J van Ommen; C Brahe; C H Buys
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

4.  Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid.

Authors:  Illora A Darbar; Paulo G Plaggert; Maria Bernadete D Resende; Edmar Zanoteli; Umbertina C Reed
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

5.  Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.

Authors:  John N Milligan; Jessica L Larson; Stela Filipovic-Sadic; Walairat Laosinchai-Wolf; Ya-Wen Huang; Tsang-Ming Ko; Kristin M Abbott; Henny H Lemmink; Minna Toivonen; Johanna Schleutker; Caren Gentile; Vivianna M Van Deerlin; Huiping Zhu; Gary J Latham
Journal:  J Mol Diagn       Date:  2021-03-30       Impact factor: 5.341

Review 6.  Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.

Authors:  Ingrid E C Verhaart; Agata Robertson; Ian J Wilson; Annemieke Aartsma-Rus; Shona Cameron; Cynthia C Jones; Suzanne F Cook; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2017-07-04       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.